Promising clinical and pathological response rates with neoadjuvant sequential doxorubicine (DOX) and docetaxel (DOC) in locally advanced breast cancer (LABC)

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2002-03, Vol.38 (11), p.S66
Main Author: Wynendaele, W
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0959-8049
DOI:10.1016/S0959-8049(02)80194-0